NOVOS Boost is an NMN supplement with a relatively simple product identity. It should be distinguished from NOVOS Core, a different multi-ingredient formula sold by the same company.
That distinction matters when reading clinical-study language. A trial of another NOVOS product cannot establish what Boost itself does.
Boost offers an identifiable NMN option. Its ingredient research and lower prepaid bottle prices still need to be read in their proper context.
What is the labeled serving?
The Boost page lists 250 mg NMN per two capsules, with 60 capsules per bottle. That makes 30 labeled servings. The number describes contents, not how much NAD reaches tissues. Compare the molecule first using NAD, NMN, and NR.
What are the public purchase options?
The checked page shows $44 one-time and $39.50 for the monthly subscription. Lower $37 and $32 per-bottle figures correspond to six and twelve bottles upfront. Those unit prices should not be presented as small monthly payments. Use the cost-per-serving guide to separate a bottle discount from the cash commitment.
Has Boost itself been clinically studied?
The manufacturer explicitly distinguishes studies of NMN from studies of finished Boost, and distinguishes Boost from Core. That is a useful disclosure. Still examine the original paper: a metabolic finding in a selected population is not a guaranteed benefit for a healthy buyer. Our research guide explains how to compare study product, duration, and endpoint.
How should testing language be assessed?
The page names third-party testing, but this review is not an independent assay. Ask for a report tied to the batch you would receive, including identity, potency, and relevant contaminants. A purity percentage alone does not answer every quality question. The certificate-of-analysis guide explains the difference between a raw-material report and a finished-product result.
What would make the product a practical fit?
A short ingredient list can simplify the task of checking overlap with an existing regimen. It does not establish that the supplement is needed or that a particular serving will improve symptoms. If a new symptom is driving the purchase, identify that problem first. Do not buy a year’s supply solely because a biological-age headline sounds persuasive.
Useful alternatives to compare
The NMN shortlist includes Solaray, Jarrow, and DoNotAge. Wonderfeel adds other ingredients, creating a different comparison. Look at the exact serving and full cost before interpreting a larger milligram number as better value.
Compare Boost with a larger NMN combination
NOVOS Boost versus Wonderfeel compares the focused 250 mg serving with Youngr’s larger NMN amount and additional actives. The NMN 250 mg guide examines the human research without presenting a matched label amount as a finished-product trial.
Sources & reading notes
Editorial source review updated September 19, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- NOVOS: Boost NMN Manufacturer explicitly distinguishes NMN ingredient research from trials of the finished Boost product. Checked September 18, 2026.
- Yoshino et al. (2021): NMN and muscle insulin sensitivity Small randomized study in postmenopausal women with prediabetes; not evidence for NAD injections or general weight loss.
- FDA: questions and answers on dietary supplements Regulatory categories and limits of premarket review.
- USP: dietary supplement verification summary Describes testing and auditing scope; quality verification is not proof of clinical benefit.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.